Cargando…
A case report: Clozapine‐induced leukopenia and neutropenia after mRNA COVID‐19 vaccination
Clozapine is an atypical antipsychotic used for treatment‐resistant schizophrenia and is known to cause serious side effects, such as leukopenia and neutropenia. We encountered the case of a 44‐year‐old female patient with a good response to clozapine, who experienced inflammatory reaction and cytop...
Autores principales: | Imai, Tomoyuki, Ochiai, Sho, Ishimaru, Takehiro, Daitoku, Hayato, Miyagawa, Yusuke, Fukuhara, Ryuji, Boku, Shuken, Takebayashi, Minoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216366/ https://www.ncbi.nlm.nih.gov/pubmed/35166466 http://dx.doi.org/10.1002/npr2.12238 |
Ejemplares similares
-
Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study
por: Chen, Jianhua, et al.
Publicado: (2021) -
Correction to: Genetic risk of clozapine-induced leukopenia and neutropenia: a genome-wide association study
por: Chen, Jianhua, et al.
Publicado: (2021) -
Late-onset attention-deficit/hyperactivity disorder as a differential diagnosis of dementia: a case report
por: Sasaki, Hiroyuki, et al.
Publicado: (2020) -
Late-manifestation of attention-deficit/hyperactivity disorder in older adults: an observational study
por: Sasaki, Hiroyuki, et al.
Publicado: (2022) -
Utilization of G-CSF and GM-CSF as an alternative to discontinuation in clozapine-induced neutropenia or leukopenia: A case report and discussion
por: Karst, Allison, et al.
Publicado: (2018)